All.Can International is pleased to share the latest publication from our national initiative, All.Can Belgium. Their new white paper, “Measuring what matters: Towards a shared framework for clinically meaningful endpoints in curative oncology”, addresses a timely and complex question at the heart of modern cancer care: how can we ensure that the endpoints used in clinical trials, access pathways and decision-making truly reflect outcomes that matter to patients, clinicians and society?